Related Experiment Video

Updated: May 15, 2026

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

The role of statins in deep vein thrombosis

Maria-Magdalena Leon1, Elena Cojocaru, Roxana Cobzaru

  • 1Discipline of Medical Semiology, University of Medicine and Pharmacy Grigore T. Popa-Iaşi School of Medicine.

Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
|January 1, 2013
PubMed

Insights

Statins may help prevent deep vein thrombosis (DVT) and reduce recurrences. Their anti-thrombotic and anti-inflammatory effects offer vasoprotective benefits, potentially preventing post-thrombotic syndrome.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Deep vein thrombosis (DVT) is a serious condition involving blood clots in deep veins, primarily the legs.
  • Current treatment goals focus on preventing clot progression and recurrence.
  • Understanding DVT pathogenesis is crucial for developing effective preventive strategies.

Purpose of the Study:

  • To elucidate the pathogenetic mechanisms of DVT.
  • To explore the potential benefits of statins in managing DVT.
  • To investigate the vasoprotective properties of statins relevant to DVT.

Main Methods:

  • Review of existing literature on DVT pathogenesis.
  • Analysis of studies on statin efficacy and mechanisms of action.
  • Examination of epidemiological data on statin use and venous thromboembolism (VTE) incidence.

Main Results:

  • Statins exhibit vasoprotective effects, including anti-thrombotic and anti-inflammatory properties.
  • Statin administration is linked to a reduced incidence of VTE in the general population.
  • Statins may decrease the frequency of DVT recurrences when used post-anticoagulation.

Conclusions:

  • Statins offer potential benefits in DVT management due to their vasoprotective actions.
  • Further research into statins could lead to new prevention strategies for post-thrombotic syndrome and recurrent VTE.
  • Statins represent a promising therapeutic avenue for improving DVT outcomes.

More Related Videos

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis05:37

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis

Published on: December 22, 2017

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...